READDI’s targets are families of viruses that have pandemic potential, and the initiative aims to get five broad-spectrum antivirals through early safety studies in humans within 5 years. One way to do that, Bamforth says, is to target host biology. “If we can affect the host cell, then, to a degree, it doesn’t matter what the virus does,” he says.
by Laura Howes |
May 20, 2021